L’essentiel de l’actualité en cardio-oncologie

Chaque semaine, retrouvez l’actualité en cardio-oncologie, sélectionnée par le Groupe de Cardio-Oncologie (GCO).

Mars

  • Effectiveness and Safety of Rivaroxaban and Low Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism >> SCIENCE DIRECT
  • Genetic Predisposition to Cardiovascular Disease in Patients With Cancer: A Clinical Perspective >> SCIENCE DIRECT

Février

  • Radiation-Induced Aortic Stenosis: An Update on Treatment Modalities >> JACC
  • Heart Valve Team Conundrum: The Optimal Management Strategy of Severe Aortic Stenosis in Cancer Patients >> JACC
  • Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial >> JAMA NETWORK
  • Coronary Artery Calcium for Cardiovascular Risk Estimation in Patients With Cancer >> AHA JOURNALS
  • Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study >> AHA JOURNALS
  • Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review >> JACC
  • Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer >> JACC
  • The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis >> JACC
  • Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer >> JACC
  • Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up >> JACC
  • Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients >> JACC
  • The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice >> JACC

Janvier

  • Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation >> JACC
  • The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice >> JACC
  • Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial >> JACC
  • Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer >> JAMA NETWORK
  • Cardiovascular outcomes in patients with cancer during a 5-year follow-up: Results from a French administrative database >> SCIENCE DIRECT